Results 51 to 60 of about 153,974 (300)

Managing malignant pleural effusion

Cleveland Clinic Journal of Medicine, 2019
Malignant pleural effusion can be managed in different ways, including clinical observation, thoracentesis, placement of an indwelling pleural catheter, and chemical pleurodesis. The optimal strategy depends on a variety of clinical factors. This article uses cases to illustrate the rationale for determining the best approach in different situations.
Ali Saeed, Wahla, Mateen, Uzbeck, Yaser Abu, El Sameed, Zaid, Zoumot   +3 more
openaire   +2 more sources

Malignant pleural mesothelioma with resolution of pleural effusion

Respirology Case Reports, 2023
Key message In malignant pleural mesothelioma patients, pleural effusion may improve during the course of the disease. Pleural effusion with nodular shadows bordering the pleura should be followed up even if the pleural effusion improves.
Sayaka Nishida, Kazutoshi Toriyama, Makiko Yomota, Yukio Hosomi   +3 more
doaj   +1 more source

Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.

The Lancet Respiratory Medicine, 2018
BACKGROUND Indwelling pleural catheters are an established management option for malignant pleural effusion and have advantages over talc slurry pleurodesis.
S. Muruganandan, S. Muruganandan, M. Azzopardi, M. Azzopardi, D. Fitzgerald, Ranjan L Shrestha, Benjamin C. H. Kwan, D. C. Lam, Christian C De Chaneet, Muhammad Ali, E. Yap, Claire Tobin, Claire Tobin, Luke A Garske, Phan Nguyễn, Phan Nguyễn, C. Stanley, N. Popowicz, N. Popowicz, Christopher Kosky, Christopher Kosky, Rajesh Thomas, Rajesh Thomas, C. Read, C. Budgeon, D. Feller-Kopman, N. Maskell, K. Murray, Y. C. G. Lee, Y. C. G. Lee   +29 more
semanticscholar   +1 more source

Diagnostic value of procalcitonin in pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2020
Background A wide range of diseases can cause pleural effusion. Its diagnosis and management remain a clinical challenge, bearing a significant cost to both patients and health care system.
Abdelsadek H Al-Aarag, Shuzan A Mohammed, Hoda Y Ibrahim, Osama I Mohammad   +3 more
doaj   +1 more source

Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion

Emergency Medicine International, 2022
Objective. The aim of the study is to investigate the clinical value of matrix metalloproteinases-3 (MMP-3) and cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) combined with adenosine deaminase (ADA) in pleural effusion and serum in benign and malignant
Zhiyang Xu, Jun Guan, Jianxin Xu, Jiahua Tu, Jiangdong Cheng   +4 more
doaj   +1 more source

Pleural Effusions in Hematologic Malignancies

Chest, 2004
Nearly all hematologic malignancies can occasionally present with or develop pleural effusions during the clinical course of disease. Among the most common disorders are Hodgkin and non-Hodgkin lymphomas, with a frequency of 20 to 30%, especially if mediastinal involvement is present.
Alexandrakis, MG, Passam, FH, Kyriakou, DS, Bouros, D   +3 more
openaire   +3 more sources

Contemporary Approach to the Diagnosis of Malignant Pleural Effusion.

Annals of the American Thoracic Society, 2019
Advanced malignancy is a prevalent cause of exudative pleural effusion. The management of malignant pleural effusion (MPE) has been the subject of several recent randomized controlled trials and excellent reviews.
V. Kaul, D. McCracken, N. Rahman, O. Epelbaum   +3 more
semanticscholar   +1 more source

Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre's 10 years of experience [PDF]

, 2020
BACKGROUND: Recurrent pleural effusion is a common cause of dyspnoea, cough and chest pain during the course of infectious pleurisy and non-malignant diseases like congestive heart failure (CHF) or liver cirrhosis with hepatic hydrothorax (HH). With
Brünger, Martin, Frost, Nikolaj, Raspe, Matthias, Ruwwe-Glösenkamp, Christoph, Suttorp, Norbert, Temmesfeld-Wollbrück, Bettina, Witzenrath, Martin   +6 more
core   +1 more source

Common Signatures of Altered Gene Regulation and Invasiveness of Different Breast Cancer Cell Lines after Matrix Interface Crossing

Advanced Healthcare Materials, EarlyView.
Interface transmigration reprograms triple‐negative breast cancer cells, triggering a shared switch toward more aggressive and invasive phenotypes. Using a collagen I interface model, this study identifies shared transcriptional changes involving proliferation, chromatin remodeling, and DNA repair pathways.
Cornelia Clemens, Hannah Trampert, Nataliia Kotsiuba, Tilo Pompe   +3 more
wiley   +1 more source

Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion

The Egyptian Journal of Bronchology, 2019
Background Pleural effusion can arise as a result of more than 50 recognized causes and the differentiation between benign and malignant origin of the fluid is still a diagnostic challenge.
Omar M. Mohammed, Kamel M. Hussein, Abdelgawad E. Ramadan, Gouda T. Mahmoud, Marwa El-Sayed El-Naggar, Nor Eldein Z. Gaber   +5 more
doaj   +1 more source